BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chen-Ta Chi, Gar-Yang Chau, Rheun-Chuan Lee, Yen-Ying Chen, Hao-Jan Lei, Ming-Chih Hou, Yee Chao, Yi-Hsiang Huang. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resectionJournal of the Formosan Medical Association 2020; 119(1): 125 doi: 10.1016/j.jfma.2019.02.012
2
Kenichiro Yamamura, Ichiro Sakamoto, Eiji Morihana, Yuichiro Hirata, Hazumu Nagata, Yuzo Yamasaki, Yukihiko Okumura, Kenichi Kohashi, Kazuhiro Koto, Hiroyuki Tsutsui, Shouichi Ohga. Elevated non-invasive liver fibrosis markers and risk of liver carcinoma in adult patients after repair of tetralogy of FallotInternational Journal of Cardiology 2019; 287: 121 doi: 10.1016/j.ijcard.2019.04.032
3
Matthew L. Holzner, Parissa Tabrizian, Fatemeh P. Parvin‐Nejad, Kezhen Fei, Ganesh Gunasekaran, Chiara Rocha, Marcelo E. Facciuto, Sander Florman, Myron E. Schwartz. Resection of Mixed Hepatocellular‐Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic CholangiocarcinomaLiver Transplantation 2020; 26(7): 888 doi: 10.1002/lt.25786
4
Jiakun Wang, Enliang Li, Hao Yang, Junjun Wu, Hong cheng Lu, Chenhao Yi, Jun Lei, Wenjun Liao, Linquan Wu. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trendsWorld Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1586-8
5
Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Fabio Sandomenico, Maria Luisa Barretta, Andrea Belli, Raffaele Palaia, Fabiana Tatangelo, Roberta Grassi, Francesco Izzo, Antonella Petrillo. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinomaRadiology and Oncology 2020; 54(2): 149 doi: 10.2478/raon-2020-0029
6
Jain Zhou, He Wang, Nirag Jhala. Practical Cytopathology2020; : 269 doi: 10.1007/978-3-030-24059-2_16
7
Yukihiko Okumura, Kenichi Kohashi, Yuki Tanaka, Masaki Kato, Yoshihiko Maehara, Yoshihiro Ogawa, Yoshinao Oda. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosisVirchows Archiv 2020; 476(6): 881 doi: 10.1007/s00428-019-02741-3
8
Anjelica Hodgson, Zuhoor Almansouri, Oyedele Adeyi, Sandra E Fischer. Gross and microscopic changes of liver neoplasms and background hepatic structures following neoadjuvant therapyJournal of Clinical Pathology 2019; 72(2): 112 doi: 10.1136/jclinpath-2018-205596
9
Susumu Tsuda, Hiromichi Maeda, Sunao Uemura, Toshichika Kanagawa, Sachi Tsuda, Toyokazu Akimori, Yuki Fujieda, Norihito Kamioka, Michiya Kobayashi, Kazuhiro Hanazaki. Sarcomatoid combined hepatocellular carcinoma and cholangiocarcinoma of liver with spontaneous intra-tumor bleeding: a case reportAnnals of Cancer Research and Therapy 2017; 25(2): 77 doi: 10.4993/acrt.25.77
10
Patricia Munoz-Garrido, Pedro M. Rodrigues. The jigsaw of dual hepatocellular–intrahepatic cholangiocarcinoma tumoursNature Reviews Gastroenterology & Hepatology 2019; 16(11): 653 doi: 10.1038/s41575-019-0185-z
11
Sun Kyung Jeon, Ijin Joo, Dong Ho Lee, Sang Min Lee, Hyo-Jin Kang, Kyoung-Bun Lee, Jeong Min Lee. Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imagingEuropean Radiology 2019; 29(1): 373 doi: 10.1007/s00330-018-5605-x
12
The Role of Autophagy in Liver Epithelial Cells and Its Impact on Systemic HomeostasisNutrients 2019; 11(4): 827 doi: 10.3390/nu11040827
13
Samuel O. Antwi, Yacob Y. Habboush, Lori A. Chase, David D. Lee, Tushar Patel. Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-CholangiocarcinomaAnnals of Hepatology 2018; 17(6): 969 doi: 10.5604/01.3001.0012.7197
14
Bo Du, Peng Zhang, Zhiming Tan, Jifan Xu. MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14Biomedicine & Pharmacotherapy 2017; 96: 1246 doi: 10.1016/j.biopha.2017.11.090
15
Shintaro Ichikawa, Hiroyoshi Isoda, Tatsuya Shimizu, Daiki Tamada, Kojiro Taura, Kaori Togashi, Hiroshi Onishi, Utaroh Motosugi. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center studyEuropean Radiology 2020;  doi: 10.1007/s00330-020-06972-w
16
Kazuki Wakizaka, Hideki Yokoo, Toshiya Kamiyama, Masafumi Ohira, Koichi Kato, Yuki Fujii, Ko Sugiyama, Naoki Okada, Takanori Ohata, Akihisa Nagatsu, Shingo Shimada, Tatsuya Orimo, Hirofumi Kamachi, Akinobu Taketomi. Clinical and pathological features of combined hepatocellular–cholangiocarcinoma compared with other liver cancersJournal of Gastroenterology and Hepatology 2019; 34(6): 1074 doi: 10.1111/jgh.14547
17
Ruben Manuel Luciano Colunga Biancatelli, Marco Ciacciarelli, Alessandro Polidoro, Piera Clemenzi, Viviana Congedo, Leonardo Calvosa, Eleonora D’Armiento, Carmen Misurale, Davide Bellini, Stefano Badia, Massimiliano Mancini, Vincenzo Petrozza, Luigi Iuliano. Combined Hepatocholangiocarcinoma Associated with Humoral Hypercalcemia of Malignancy and Chronic Inflammatory Demyelinating PolyneuropathyCase Reports in Oncological Medicine 2019; 2019: 1 doi: 10.1155/2019/3418950